3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Cancer Screening Rates Low Among Older Medicaid Patients

CancerOct 13, 08

Only about half of Medicaid recipients age 50 and older appear to receive recommended screening tests for colorectal, breast and cervical cancer, according to a report in the October 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

These three types of cancer are potentially curable when detected early, and eliminating disparities in screenings is part of the government’s Healthy People 2010 plan, according to background information in the article. “State Medicaid agencies are in a unique position to monitor and improve the quality of care received by some of the nation’s most vulnerable citizens,” the authors write. “Medicaid is the largest provider of health insurance for minority populations in America. Medicaid recipients, by virtue of Medicaid eligibility criteria, frequently share other characteristics associated with health-related disparities: low income, old age, and/or chronic disability because of advanced disease, physical limitation, severe mental illness or developmental disability.”

C. Annette DuBard, M.D., M.P.H., of the North Carolina Department of Health and Human Services, Raleigh, and the University of North Carolina at Chapel Hill Cecil G. Sheps Center for Health Services Research, and colleagues studied a representative sample of 1,951 North Carolina Medicaid recipients age 50 and older. Medical records were reviewed to determine whether physicians had recommended and patients had received cancer screening examinations.

“Documentation that colorectal, breast and cervical cancer screening was recommended by the primary care provider was found for only 52.7 percent, 60.4 percent and 51.5 percent of eligible patients, respectively,” the authors write. “Documented rates of adequate screening were 28.2 percent for colorectal cancer, 31.7 percent for mammography within two years and 31.6 percent for Papanicolaou [cervical cancer] test within three years. When medical record and claims data were combined, approximately half of eligible patients had evidence of screening.”

Despite Medicaid recipients’ access to primary care and full coverage of cancer screening services, these rates are substantially lower than those in the general population, the authors note. “Lack of a screening recommendation by the physician, rather than patient refusal of recommended tests, accounted for most instances of screening delinquency,” they conclude. “Efforts to increase cancer screening rates among Medicaid recipients must address patient, physician and organizational barriers to the routine identification and delivery of preventive services.”

(Arch Intern Med. 2008;168[18]:2014-2021. Available pre-embargo to the media at http://www.jamamedia.org.)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.


Source: American Medical Association (AMA)



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site